but the source of the androgen(s) from which they are synthesized is not known. The present report describes the levels of androstenedione in sheep before parturition.
10 of the ewes, parturition was induced before term by intra-fetal administration of dexamethasone phosphate (Liggins, 1969) , given i.m. (25 mg) at operation for catheterization to 6 ewes and infused from 5 days (1 mg/day) after the operation in the others. In 2 ewes, samples were obtained after the spontaneous onset of labour at term (Days 144 and 147 post coitum). All ewes gave birth to live lambs.
Androstenedione was measured by radioimmunoassay using an antibody raised against androstenedione 6-bovine serum albumin (Steraloids Inc., Pawling, New York). Plasma (0-5 ml) was extracted with 5 ml diethyl ether ; after drying 1-0-3-5 ml of the ether extract, the residue was dissolved in 0-5 ml assay buffer (0-9 % NaCl, 0-1 % gelatin and 0-1 % sodium azide in 100 mM-sodium phosphate, pH 7-2) containing antiserum (final dilution 1:50,000) and [l,2-3H] androstenedione (60 nCi, Ci/mmol; New England Nuclear Chemicals, GmbH, Dreieichenhain, West Germany). After incubation for 3-18 hr at 4°C, free and bound steroid were separated by adding 0-5 ml of a suspension of dextran-coated charcoal in assay buffer; antibody-bound steroid remaining in the supernatant was measured by ß-scintillation counting after brief centrifugation, and levels were computed by reference to a standard curve (0-700 pg androstenedione). The following compounds were tested for cross-reactivity (values in parentheses): 5a-androstane-3a,17a-and 17ß-diols, 4-androstene-3ß,17ß-diol, 5-androstene-3ß,17ß-diol, Cortisol, dexamethasone, oestrone and oestradiol (<0-03%); progesterone and 17ct,20a-dihydroxypregn-4-en-3-one (0-2%); testosterone (0-6%); 5ct-dihydrotestosterone (2%); dehydroepiandrosterone (8%); androsterone (11%); 5a-androstane-3,17-dione (40%). The within-assay and between-assay coefficients of variation were 14% (at 2 ng/ml) and 17% (at 1 ng/ml), respectively. Extraction with ether was 90% efficient; losses were not monitored. Comparison of concentrations measured by the above procedure (Method ) with those determined in the same ovine utero-ovarian and jugular venous samples after celite column chromatography (Challis, Davies & Ryan, 1973 ; Method X) gave a mean ratio (Method Y : Method X) of l-3±0-40 (+S.D., n=15) and a correlation coefficient of 0-94. Progesterone, total unconjugated oestrogens and 17a,20a-dihydroxypregn-4-en-3-one were assayed as described by Flint, Anderson, Patten & Turnbull (1974) and Flint, Goodson & Turnbull (1975) . The androstenedione concentrations during the 6 hr before parturition are shown in 139post coitum). In 9 animals in which parturition was induced by dexamethasone, the mean uteroovarian venous level during the 6 hr before birth was 1054±363 pg/ml (n=37; d.f.=15; P<0-001).
Levels during labour were the same whether dexamethasone was infused or injected ( >0·01), and were unrelated to the sex of the lamb(s). Since there is no evidence that uterine blood flow decreases before birth, these data suggest an increase in the uterine or ovarian androstenedione production rate before parturition.
To determine when, in relation to other hormonal changes, the androstenedione level increases, utero-ovarian venous androstenedione, progesterone and total unconjugated oestrogens were measured in serial samples from 7 ewes during the induction of labour with dexamethasone; 17a,20a-dihydroxypregn-4-en-3-one, which also rises before term (Flint et al, 1975) , was measured in 4 of these animals. A typical series of measurements is shown in Table 2 . The increase in androstenedione occurred at approximately the same time as the increases in total unconjugated oestrogens and 17a,20a-dihydroxypregn-4-en-3-one. In Ewe 167, the fetal androstenedione concen¬ tration («=10) increased in parallel with the maternal utero-ovarian venous levels (n=7). 
